PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung cancer |
| Phenotype | C0024115|lung diseases |
| Sentences | 8 |
| PubMedID- 22064654 | Extracellular superoxide dismutase (ecsod) is an important superoxide scavenger in the lung in which its loss, sequence variation, or abnormal expression contributes to lung diseases; however, the role of ecsod in lung cancer has yet to be studied. |
| PubMedID- 25352311 | Objective: lung cancer patients with interstitial lung diseases (ilds) who have undergone pulmonary resection often develop acute exacerbation of interstitial pneumonia (ae) in the post-operative period. |
| PubMedID- 25439777 | We evaluated the survival and predictors of survival after surgical resection in lung cancers in patients with interstitial lung diseases. |
| PubMedID- 22134685 | Positive rates for p16 msp were 63.1% in sputa of lung cancer patients, 39.7% in patients with benign lung diseases, and 3.3% in healthy people. |
| PubMedID- 21828236 | Background: inflammation and pulmonary diseases, including interstitial lung diseases, are associated with increased lung cancer risk. |
| PubMedID- 23336716 | The treatment of lung diseases including lung cancer and tuberculosis is one of the most challenging problems in clinical practice, because the conventional drug delivery systems cannot deliver drug effectively to the lung, which result in low therapeutic effect. |
| PubMedID- 22435300 | Lower silesian centre of lung diseases, diagnosed with lung cancer. |
| PubMedID- 24267779 | Objective: the study objective was to examine the incidence, risk factors, and mortality rate of acute exacerbation of interstitial lung diseases in patients with lung cancer undergoing pulmonary resection in a large-scale multi-institutional cohort. |
Page: 1